Ignite Creation Date:
2025-12-24 @ 6:47 PM
Ignite Modification Date:
2026-05-17 @ 8:44 AM
Study NCT ID:
NCT00996957
Status:
COMPLETED
Last Update Posted:
2013-03-18
First Post:
2009-10-09
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Study of ACE-041 in Patients With Advanced Solid Tumors or Relapsed/Refractory Multiple Myeloma
Sponsor:
Acceleron Pharma, Inc., a wholly-owned subsidiary of Merck & Co., Inc., Rahway, NJ USA
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
A041-01
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None